Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.
Akira MizutaniShuichiro FujinagaKoji SakurayaDaishi HiranoToshiaki ShimizuPublished in: Clinical and experimental nephrology (2018)
Single daily high-dose MZR therapy after CPM therapy may have positive outcomes in young children with SDNS in the long term.